Review



α syn pffs  (StressMarq)


Bioz Verified Symbol StressMarq is a verified supplier
Bioz Manufacturer Symbol StressMarq manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    StressMarq α syn pffs
    LRP1 expression is increased in the nigrostriatal system of a monkey model of PD induced by α-syn <t>PFFs</t> injection. (A) Clinical rating score of monkeys after stereotactic injection of 600 μg of α-syn PFFs or an equal volume of normal saline for 4 months. (B) Immunohistochemistry detection of TH in the STR (left) and SN (right). The TH signal intensity in the STR and the number of TH-positive neurons in the SN were lower in the PFF group. The black arrow heads indicate typical TH-positive neurons. Scale bars: 100 μm. (C) Quantitative immunohistochemistry density analysis of TH in the STR. (D) Quantitation of the ratio of TH-positive neurons in the SN in the PFF group compared with the Sham group. (E) Western blot analysis of TH, LRP1, and α-syn expression levels in the monkey STR. (F–H) Densitometric analysis of TH (F), LRP1 (G), and α-syn (H) expression levels in the STR. (I) Western blot analysis of TH, LRP1, and α-syn expression levels in the monkey SN. (J–L) Densitometric analysis of TH (J), LRP1 (K), and α-syn (L) expression levels in the SN. Data are expressed as mean ± SD ( n = 3). * P < 0.05, ** P < 0.01, *** P < 0.001, vs. Sham group (unpaired t -test). LRP1: Low-density lipoprotein receptor-related protein 1; PD: Parkinson’s disease; PFF: pre-formed fibril; SN: substantia nigra; STR: striatum; TH: tyrosine hydroxylase; α-syn: α-synuclein.
    α Syn Pffs, supplied by StressMarq, used in various techniques. Bioz Stars score: 95/100, based on 42 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pff/pmc12407564-84-0-3?v=StressMarq
    Average 95 stars, based on 42 article reviews
    α syn pffs - by Bioz Stars, 2026-07
    95/100 stars

    Images

    1) Product Images from "Low-density lipoprotein receptor–related protein 1 mediates α-synuclein transmission from the striatum to the substantia nigra in animal models of Parkinson’s disease"

    Article Title: Low-density lipoprotein receptor–related protein 1 mediates α-synuclein transmission from the striatum to the substantia nigra in animal models of Parkinson’s disease

    Journal: Neural Regeneration Research

    doi: 10.4103/NRR.NRR-D-23-01965

    LRP1 expression is increased in the nigrostriatal system of a monkey model of PD induced by α-syn PFFs injection. (A) Clinical rating score of monkeys after stereotactic injection of 600 μg of α-syn PFFs or an equal volume of normal saline for 4 months. (B) Immunohistochemistry detection of TH in the STR (left) and SN (right). The TH signal intensity in the STR and the number of TH-positive neurons in the SN were lower in the PFF group. The black arrow heads indicate typical TH-positive neurons. Scale bars: 100 μm. (C) Quantitative immunohistochemistry density analysis of TH in the STR. (D) Quantitation of the ratio of TH-positive neurons in the SN in the PFF group compared with the Sham group. (E) Western blot analysis of TH, LRP1, and α-syn expression levels in the monkey STR. (F–H) Densitometric analysis of TH (F), LRP1 (G), and α-syn (H) expression levels in the STR. (I) Western blot analysis of TH, LRP1, and α-syn expression levels in the monkey SN. (J–L) Densitometric analysis of TH (J), LRP1 (K), and α-syn (L) expression levels in the SN. Data are expressed as mean ± SD ( n = 3). * P < 0.05, ** P < 0.01, *** P < 0.001, vs. Sham group (unpaired t -test). LRP1: Low-density lipoprotein receptor-related protein 1; PD: Parkinson’s disease; PFF: pre-formed fibril; SN: substantia nigra; STR: striatum; TH: tyrosine hydroxylase; α-syn: α-synuclein.
    Figure Legend Snippet: LRP1 expression is increased in the nigrostriatal system of a monkey model of PD induced by α-syn PFFs injection. (A) Clinical rating score of monkeys after stereotactic injection of 600 μg of α-syn PFFs or an equal volume of normal saline for 4 months. (B) Immunohistochemistry detection of TH in the STR (left) and SN (right). The TH signal intensity in the STR and the number of TH-positive neurons in the SN were lower in the PFF group. The black arrow heads indicate typical TH-positive neurons. Scale bars: 100 μm. (C) Quantitative immunohistochemistry density analysis of TH in the STR. (D) Quantitation of the ratio of TH-positive neurons in the SN in the PFF group compared with the Sham group. (E) Western blot analysis of TH, LRP1, and α-syn expression levels in the monkey STR. (F–H) Densitometric analysis of TH (F), LRP1 (G), and α-syn (H) expression levels in the STR. (I) Western blot analysis of TH, LRP1, and α-syn expression levels in the monkey SN. (J–L) Densitometric analysis of TH (J), LRP1 (K), and α-syn (L) expression levels in the SN. Data are expressed as mean ± SD ( n = 3). * P < 0.05, ** P < 0.01, *** P < 0.001, vs. Sham group (unpaired t -test). LRP1: Low-density lipoprotein receptor-related protein 1; PD: Parkinson’s disease; PFF: pre-formed fibril; SN: substantia nigra; STR: striatum; TH: tyrosine hydroxylase; α-syn: α-synuclein.

    Techniques Used: Expressing, Injection, Saline, Immunohistochemistry, Quantitation Assay, Western Blot

    LRP1 expression is increased in the nigrostriatal system of a mouse model of PD induced by injection with α-Syn PFFs. (A) Visual gait analysis of walking, gait, and footprint pressure in mice after stereotactic injection with 5 μg of α-Syn PFFs or an equal volume of PBS for 4 weeks ( n = 6). (B) Normal step sequence in mice ( n = 6). (C) Average speed in mice ( n = 6). (D) Tripod support time in mice ( n = 6). (E) Immunohistochemistry staining for TH in the STR. The images in the second row are enlarged images of the areas indicated in black boxes in the upper row. The TH signal intensity in the STR was lower in the PFF group. Scale bars: 200 μm, 40 μm (enlarged). (F) Immunohistochemistry staining for TH in the SN. The images in the second row are enlarged images of the areas indicated in black boxes in the upper row, and the white arrowheads indicate typical TH-positive neurons. There were fewer TH-positive neurons in the SN in the PFF group. Scale bars: 100 μm, 20 μm (enlarged). (G) Quantitative immunohistochemistry density analysis of TH in the STR, compared with the Sham group ( n = 3). (H) Quantitation of the ratio of TH-positive neurons in the SN in the PFF group compared with the Sham group ( n = 3). (I) Western blot analysis of TH, LRP1, and α-Syn expression levels in the mouse STR after injection with 5 μg of α-Syn PFFs or an equal volume of PBS ( n = 3). (J–L) Densitometric analysis of TH (J), LRP1 (K), and α-Syn (L) expression levels in the STR. (M) Western blot analysis of TH, LRP1, and α-Syn expression levels in the mouse SN ( n = 3). (N–P) Densitometric analysis of TH (N), LRP1 (O), and α-Syn (P) expression levels in the SN ( n = 3). Data are expressed as mean ± SD ( n = 3). * P < 0.05, ** P < 0.01, *** P < 0.001, vs . Sham group (unpaired t -test). LRP1: Low-density lipoprotein receptor-related protein 1; PBS: phosphate buffered solution; PD: Parkinson’s disease; PFF: pre-formed fibril; SN: substantia nigra; STR: striatum; TH: tyrosine hydroxylase; α-Syn: α-synuclein.
    Figure Legend Snippet: LRP1 expression is increased in the nigrostriatal system of a mouse model of PD induced by injection with α-Syn PFFs. (A) Visual gait analysis of walking, gait, and footprint pressure in mice after stereotactic injection with 5 μg of α-Syn PFFs or an equal volume of PBS for 4 weeks ( n = 6). (B) Normal step sequence in mice ( n = 6). (C) Average speed in mice ( n = 6). (D) Tripod support time in mice ( n = 6). (E) Immunohistochemistry staining for TH in the STR. The images in the second row are enlarged images of the areas indicated in black boxes in the upper row. The TH signal intensity in the STR was lower in the PFF group. Scale bars: 200 μm, 40 μm (enlarged). (F) Immunohistochemistry staining for TH in the SN. The images in the second row are enlarged images of the areas indicated in black boxes in the upper row, and the white arrowheads indicate typical TH-positive neurons. There were fewer TH-positive neurons in the SN in the PFF group. Scale bars: 100 μm, 20 μm (enlarged). (G) Quantitative immunohistochemistry density analysis of TH in the STR, compared with the Sham group ( n = 3). (H) Quantitation of the ratio of TH-positive neurons in the SN in the PFF group compared with the Sham group ( n = 3). (I) Western blot analysis of TH, LRP1, and α-Syn expression levels in the mouse STR after injection with 5 μg of α-Syn PFFs or an equal volume of PBS ( n = 3). (J–L) Densitometric analysis of TH (J), LRP1 (K), and α-Syn (L) expression levels in the STR. (M) Western blot analysis of TH, LRP1, and α-Syn expression levels in the mouse SN ( n = 3). (N–P) Densitometric analysis of TH (N), LRP1 (O), and α-Syn (P) expression levels in the SN ( n = 3). Data are expressed as mean ± SD ( n = 3). * P < 0.05, ** P < 0.01, *** P < 0.001, vs . Sham group (unpaired t -test). LRP1: Low-density lipoprotein receptor-related protein 1; PBS: phosphate buffered solution; PD: Parkinson’s disease; PFF: pre-formed fibril; SN: substantia nigra; STR: striatum; TH: tyrosine hydroxylase; α-Syn: α-synuclein.

    Techniques Used: Expressing, Injection, Sequencing, Immunohistochemistry, Staining, Quantitation Assay, Western Blot

    Exogenous α-syn PFFs upregulate LRP1 expression in PC12 cells. (A) Viability of PC12 cells incubated with different doses (0, 5, 10, 20, or 50 µg/mL) of α-Syn PFFs for 24 hours. ** P < 0.01, *** P < 0.001, vs . 0 µg/mL group. (B) Western blot analysis of LRP1 and α-syn expression levels in PC12 cells. (C, D) Densitometric analysis of LRP1 (C) and α-syn (D) expression levels. (E) Immunofluorescence analysis of LRP1 (green, Alexa Fluor 488), α-syn (red, Alexa Fluor 594), and DAPI (blue) expression. The LRP1 and α-syn signal intensities were stronger in PFF group than in Con group. Scale bars: 40 μm. (F, G) Quantitative immunofluorescence intensity analysis of LRP1 (F) and α-syn (G). * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001, vs . Con group; # P < 0.05, ## P < 0.01, vs. monomer group. Data are expressed as mean ± SD ( n = 3). Con: Control; DAPI: 4′,6-diamidino-2-phenylindole; PFF: pre-formed fibril; LRP1: low-density lipoprotein receptor-related protein 1; α-syn: α-synuclein.
    Figure Legend Snippet: Exogenous α-syn PFFs upregulate LRP1 expression in PC12 cells. (A) Viability of PC12 cells incubated with different doses (0, 5, 10, 20, or 50 µg/mL) of α-Syn PFFs for 24 hours. ** P < 0.01, *** P < 0.001, vs . 0 µg/mL group. (B) Western blot analysis of LRP1 and α-syn expression levels in PC12 cells. (C, D) Densitometric analysis of LRP1 (C) and α-syn (D) expression levels. (E) Immunofluorescence analysis of LRP1 (green, Alexa Fluor 488), α-syn (red, Alexa Fluor 594), and DAPI (blue) expression. The LRP1 and α-syn signal intensities were stronger in PFF group than in Con group. Scale bars: 40 μm. (F, G) Quantitative immunofluorescence intensity analysis of LRP1 (F) and α-syn (G). * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001, vs . Con group; # P < 0.05, ## P < 0.01, vs. monomer group. Data are expressed as mean ± SD ( n = 3). Con: Control; DAPI: 4′,6-diamidino-2-phenylindole; PFF: pre-formed fibril; LRP1: low-density lipoprotein receptor-related protein 1; α-syn: α-synuclein.

    Techniques Used: Expressing, Incubation, Western Blot, Immunofluorescence, Control

    LRP1 knockdown rescues the dopaminergic damage induced by exogenous α-syn PFFs. (A, B) Western blot analysis (A) and densitometric analysis (B) of TH expression levels in the STR of mice treated with PFFs. (C, D) Western blot analysis (C) and densitometric analysis (D) of TH expression levels in the SN of mice treated with PFFs. (E) Immunohistochemistry staining for TH in the STR of mice treated with PFFs and LRP1 siRNA. The decrease in relative TH intensity in STR observed in the PFF group was rescued by LRP1 siRNA treatment. The images in the second row are enlarged images of the areas indicated by black boxes in the upper row. Scale bars: 200 μm, 40 μm (enlarged). (F) Quantitative immunohistochemistry density analysis of TH in the STR. (G) Immunohistochemistry analysis of TH in the SN of mice treated with PFFs. The decreased ratio of TH-positive neurons in the SN of the Scramble + PFF group (PFF group) was rescued by LRP1 siRNA treatment. The images in the second row are enlarged images of the areas indicated by black boxes in the upper row, and the white arrowheads indicate typical TH-positive neurons. Scale bars: 100 μm, 20 μm (enlarged). (H) Quantitation of the ratio of TH-positive neurons in the SN compared with the PBS group. Data are expressed as mean ± SD ( n = 3). * P < 0.05, ** P < 0.01, *** P < 0.001, vs. Scramble + PBS group (PBS group); # P < 0.05, ## P < 0.01, vs. scramble + PFF group (PFF group). LRP1: Low-density lipoprotein receptor-related protein 1; PBS: phosphate buffered solution; PFF: pre-formed fibril; siRNA: small interfering RNA; SN: substantia nigra; STR: striatum; TH: tyrosine hydroxylase; α-syn: α-synuclein.
    Figure Legend Snippet: LRP1 knockdown rescues the dopaminergic damage induced by exogenous α-syn PFFs. (A, B) Western blot analysis (A) and densitometric analysis (B) of TH expression levels in the STR of mice treated with PFFs. (C, D) Western blot analysis (C) and densitometric analysis (D) of TH expression levels in the SN of mice treated with PFFs. (E) Immunohistochemistry staining for TH in the STR of mice treated with PFFs and LRP1 siRNA. The decrease in relative TH intensity in STR observed in the PFF group was rescued by LRP1 siRNA treatment. The images in the second row are enlarged images of the areas indicated by black boxes in the upper row. Scale bars: 200 μm, 40 μm (enlarged). (F) Quantitative immunohistochemistry density analysis of TH in the STR. (G) Immunohistochemistry analysis of TH in the SN of mice treated with PFFs. The decreased ratio of TH-positive neurons in the SN of the Scramble + PFF group (PFF group) was rescued by LRP1 siRNA treatment. The images in the second row are enlarged images of the areas indicated by black boxes in the upper row, and the white arrowheads indicate typical TH-positive neurons. Scale bars: 100 μm, 20 μm (enlarged). (H) Quantitation of the ratio of TH-positive neurons in the SN compared with the PBS group. Data are expressed as mean ± SD ( n = 3). * P < 0.05, ** P < 0.01, *** P < 0.001, vs. Scramble + PBS group (PBS group); # P < 0.05, ## P < 0.01, vs. scramble + PFF group (PFF group). LRP1: Low-density lipoprotein receptor-related protein 1; PBS: phosphate buffered solution; PFF: pre-formed fibril; siRNA: small interfering RNA; SN: substantia nigra; STR: striatum; TH: tyrosine hydroxylase; α-syn: α-synuclein.

    Techniques Used: Knockdown, Western Blot, Expressing, Immunohistochemistry, Staining, Quantitation Assay, Small Interfering RNA

    LRP1 suppression reduces the transmission of exogenous α-syn in vivo . (A) Immunofluorescence staining for LRP1 (green, Alexa Fluor 488), α-syn (red, Alexa Fluor 594), and DAPI (blue) in the mouse STR after stereotactic injection with α-syn PFFs for 6 weeks with or without LRP1 knockdown. The increase in the relative fluorescence intensity of LRP1 and α-syn in the STR of PFFs-treated mice was rescued by LRP1 siRNA treatment. Scale bars: 100 μm. (B, C) Quantitative immunofluorescence intensity of LRP1 (B) and α-syn (C) in mouse STR. (D) Immunofluorescence staining for LRP1 (green, Alexa Fluor 488), α-syn (red, Alexa Fluor 594), and DAPI (blue) in the SN of mice after stereotactic injection with α-syn PFFs for 6 weeks with or without LRP1 knockdown. The increase in the relative fluorescence intensity of LRP1 and α-syn in the SN of mice treated with PFFs was rescued by LRP1 siRNA treatment. The white arrowheads indicate typical cells exhibiting α-syn and LRP1 expression. Scale bars: 100 μm. (E, F) Quantitative immunofluorescence intensity of LRP1 (E) and α-syn (F) in the mouse SN. (G) Western blot analysis of LRP1 and α-syn expression levels in the mouse STR. (H, I) Densitometric analysis of LRP1 (H) and α-syn (I) expression levels in the mouse STR. (J) Western blot analysis of LRP1 and α-syn expression levels in the mouse SN. (K, L) Densitometric analysis of LRP1 (K) and α-syn (L) expression levels in the mouse SN. Data are expressed as mean ± SD ( n = 3). * P < 0.05, ** P < 0.01, vs. Scramble + PBS group (PBS group); # P < 0.05, ## P < 0.01, vs . Scramble + PFF group (PFF group). DAPI: 4′,6-Diamidino-2-phenylindole; LRP1: low-density lipoprotein receptor-related protein 1; PBS: phosphate buffered solution; PFF: pre-formed fibril; siRNA: small interfering RNA; SN: substantia nigra; STR: striatum; α-syn: α-synuclein.
    Figure Legend Snippet: LRP1 suppression reduces the transmission of exogenous α-syn in vivo . (A) Immunofluorescence staining for LRP1 (green, Alexa Fluor 488), α-syn (red, Alexa Fluor 594), and DAPI (blue) in the mouse STR after stereotactic injection with α-syn PFFs for 6 weeks with or without LRP1 knockdown. The increase in the relative fluorescence intensity of LRP1 and α-syn in the STR of PFFs-treated mice was rescued by LRP1 siRNA treatment. Scale bars: 100 μm. (B, C) Quantitative immunofluorescence intensity of LRP1 (B) and α-syn (C) in mouse STR. (D) Immunofluorescence staining for LRP1 (green, Alexa Fluor 488), α-syn (red, Alexa Fluor 594), and DAPI (blue) in the SN of mice after stereotactic injection with α-syn PFFs for 6 weeks with or without LRP1 knockdown. The increase in the relative fluorescence intensity of LRP1 and α-syn in the SN of mice treated with PFFs was rescued by LRP1 siRNA treatment. The white arrowheads indicate typical cells exhibiting α-syn and LRP1 expression. Scale bars: 100 μm. (E, F) Quantitative immunofluorescence intensity of LRP1 (E) and α-syn (F) in the mouse SN. (G) Western blot analysis of LRP1 and α-syn expression levels in the mouse STR. (H, I) Densitometric analysis of LRP1 (H) and α-syn (I) expression levels in the mouse STR. (J) Western blot analysis of LRP1 and α-syn expression levels in the mouse SN. (K, L) Densitometric analysis of LRP1 (K) and α-syn (L) expression levels in the mouse SN. Data are expressed as mean ± SD ( n = 3). * P < 0.05, ** P < 0.01, vs. Scramble + PBS group (PBS group); # P < 0.05, ## P < 0.01, vs . Scramble + PFF group (PFF group). DAPI: 4′,6-Diamidino-2-phenylindole; LRP1: low-density lipoprotein receptor-related protein 1; PBS: phosphate buffered solution; PFF: pre-formed fibril; siRNA: small interfering RNA; SN: substantia nigra; STR: striatum; α-syn: α-synuclein.

    Techniques Used: Transmission Assay, In Vivo, Immunofluorescence, Staining, Injection, Knockdown, Fluorescence, Expressing, Western Blot, Small Interfering RNA

    LRP1 mediates the uptake of α-syn PFFs by PC12 cells. (A) Western blot analysis of LRP1 and α-syn expression levels in PC12 cells with or without LRP1 knockdown (10 nM siRNA) after incubation with 10 µg/mL α-syn PFFs for 24 hours. (B, C) Densitometric analysis of LRP1 (B) and α-syn (C) expression. (D) Immunofluorescence staining for LRP1 (green, Alexa Fluor 488), α-syn (red, Alexa Fluor 594), and DAPI (blue). The increase in the relative fluorescence intensity levels of LRP1 and α-syn in the PFF group was rescued by LRP1 siRNA treatment. Scale bars: 40 μm. (E, F) Quantitative immunofluorescence intensity analysis of LRP1 (E) and α-syn (F). Data are expressed as mean ± SD ( n = 3). ** P < 0.01, *** P < 0.001, **** P < 0.0001, vs . Con group; # P < 0.05, ## P < 0.01, #### P < 0.0001, vs . PFF/– group. Con: Control; DAPI: 4′, 6-diamidino-2-phenylindole; PFF: pre-formed fibril; LRP1: low-density lipoprotein receptor-related protein 1; siRNA: small interfering RNA; α-syn: α-synuclein.
    Figure Legend Snippet: LRP1 mediates the uptake of α-syn PFFs by PC12 cells. (A) Western blot analysis of LRP1 and α-syn expression levels in PC12 cells with or without LRP1 knockdown (10 nM siRNA) after incubation with 10 µg/mL α-syn PFFs for 24 hours. (B, C) Densitometric analysis of LRP1 (B) and α-syn (C) expression. (D) Immunofluorescence staining for LRP1 (green, Alexa Fluor 488), α-syn (red, Alexa Fluor 594), and DAPI (blue). The increase in the relative fluorescence intensity levels of LRP1 and α-syn in the PFF group was rescued by LRP1 siRNA treatment. Scale bars: 40 μm. (E, F) Quantitative immunofluorescence intensity analysis of LRP1 (E) and α-syn (F). Data are expressed as mean ± SD ( n = 3). ** P < 0.01, *** P < 0.001, **** P < 0.0001, vs . Con group; # P < 0.05, ## P < 0.01, #### P < 0.0001, vs . PFF/– group. Con: Control; DAPI: 4′, 6-diamidino-2-phenylindole; PFF: pre-formed fibril; LRP1: low-density lipoprotein receptor-related protein 1; siRNA: small interfering RNA; α-syn: α-synuclein.

    Techniques Used: Western Blot, Expressing, Knockdown, Incubation, Immunofluorescence, Staining, Fluorescence, Control, Small Interfering RNA

    Lysine residues in the α-syn N-terminus are vital for LRP1-mediated α-Syn internalization. (A) Heatmap of amino acids in different α-syn domains. (B) Western blot analysis of LRP1 and α-Syn levels in PC12 cells after addition of α-syn PFFs (10 µg/mL) with or without capping of lysine residues for 24 hours. (C, D) Densitometric analysis of LRP1 (C) and α-syn (D) expression levels. (E) Immunofluorescence staining for LRP1 (green, Alexa Fluor 488), α-Syn (red, Alexa Fluor 594), and DAPI (blue). The increase in the relative fluorescence intensity of LRP1 and α-syn in the PFF group was rescued by lysine capping of α-syn. Scale bars: 40 μm. (F, G) Quantitative immunofluorescence intensity analysis of LRP1 (F) and α-syn (G). Data are expressed as mean ± SD ( n = 3). * P < 0.05, ** P < 0.01, **** P < 0.0001, vs. Con group; # P < 0.05, ## P < 0.01, vs . PFF group. Con: Control; DAPI: 4′,6-diamidino-2-phenylindole; LRP1: low-density lipoprotein receptor-related protein 1; NHS: sulfo-NHS acetate; PFF: pre-formed fibril; α-syn: α-synuclein.
    Figure Legend Snippet: Lysine residues in the α-syn N-terminus are vital for LRP1-mediated α-Syn internalization. (A) Heatmap of amino acids in different α-syn domains. (B) Western blot analysis of LRP1 and α-Syn levels in PC12 cells after addition of α-syn PFFs (10 µg/mL) with or without capping of lysine residues for 24 hours. (C, D) Densitometric analysis of LRP1 (C) and α-syn (D) expression levels. (E) Immunofluorescence staining for LRP1 (green, Alexa Fluor 488), α-Syn (red, Alexa Fluor 594), and DAPI (blue). The increase in the relative fluorescence intensity of LRP1 and α-syn in the PFF group was rescued by lysine capping of α-syn. Scale bars: 40 μm. (F, G) Quantitative immunofluorescence intensity analysis of LRP1 (F) and α-syn (G). Data are expressed as mean ± SD ( n = 3). * P < 0.05, ** P < 0.01, **** P < 0.0001, vs. Con group; # P < 0.05, ## P < 0.01, vs . PFF group. Con: Control; DAPI: 4′,6-diamidino-2-phenylindole; LRP1: low-density lipoprotein receptor-related protein 1; NHS: sulfo-NHS acetate; PFF: pre-formed fibril; α-syn: α-synuclein.

    Techniques Used: Western Blot, Expressing, Immunofluorescence, Staining, Fluorescence, Control



    Similar Products

    95
    StressMarq α syn pffs
    LRP1 expression is increased in the nigrostriatal system of a monkey model of PD induced by α-syn <t>PFFs</t> injection. (A) Clinical rating score of monkeys after stereotactic injection of 600 μg of α-syn PFFs or an equal volume of normal saline for 4 months. (B) Immunohistochemistry detection of TH in the STR (left) and SN (right). The TH signal intensity in the STR and the number of TH-positive neurons in the SN were lower in the PFF group. The black arrow heads indicate typical TH-positive neurons. Scale bars: 100 μm. (C) Quantitative immunohistochemistry density analysis of TH in the STR. (D) Quantitation of the ratio of TH-positive neurons in the SN in the PFF group compared with the Sham group. (E) Western blot analysis of TH, LRP1, and α-syn expression levels in the monkey STR. (F–H) Densitometric analysis of TH (F), LRP1 (G), and α-syn (H) expression levels in the STR. (I) Western blot analysis of TH, LRP1, and α-syn expression levels in the monkey SN. (J–L) Densitometric analysis of TH (J), LRP1 (K), and α-syn (L) expression levels in the SN. Data are expressed as mean ± SD ( n = 3). * P < 0.05, ** P < 0.01, *** P < 0.001, vs. Sham group (unpaired t -test). LRP1: Low-density lipoprotein receptor-related protein 1; PD: Parkinson’s disease; PFF: pre-formed fibril; SN: substantia nigra; STR: striatum; TH: tyrosine hydroxylase; α-syn: α-synuclein.
    α Syn Pffs, supplied by StressMarq, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pff/pmc12407564-84-0-3?v=StressMarq
    Average 95 stars, based on 1 article reviews
    α syn pffs - by Bioz Stars, 2026-07
    95/100 stars
      Buy from Supplier

    86
    El Nasr Pharmaceutical Chemicals Company profenofos pff
    LRP1 expression is increased in the nigrostriatal system of a monkey model of PD induced by α-syn <t>PFFs</t> injection. (A) Clinical rating score of monkeys after stereotactic injection of 600 μg of α-syn PFFs or an equal volume of normal saline for 4 months. (B) Immunohistochemistry detection of TH in the STR (left) and SN (right). The TH signal intensity in the STR and the number of TH-positive neurons in the SN were lower in the PFF group. The black arrow heads indicate typical TH-positive neurons. Scale bars: 100 μm. (C) Quantitative immunohistochemistry density analysis of TH in the STR. (D) Quantitation of the ratio of TH-positive neurons in the SN in the PFF group compared with the Sham group. (E) Western blot analysis of TH, LRP1, and α-syn expression levels in the monkey STR. (F–H) Densitometric analysis of TH (F), LRP1 (G), and α-syn (H) expression levels in the STR. (I) Western blot analysis of TH, LRP1, and α-syn expression levels in the monkey SN. (J–L) Densitometric analysis of TH (J), LRP1 (K), and α-syn (L) expression levels in the SN. Data are expressed as mean ± SD ( n = 3). * P < 0.05, ** P < 0.01, *** P < 0.001, vs. Sham group (unpaired t -test). LRP1: Low-density lipoprotein receptor-related protein 1; PD: Parkinson’s disease; PFF: pre-formed fibril; SN: substantia nigra; STR: striatum; TH: tyrosine hydroxylase; α-syn: α-synuclein.
    Profenofos Pff, supplied by El Nasr Pharmaceutical Chemicals Company, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pff/pm41942508-73-0-3?v=El+Nasr+Pharmaceutical+Chemicals+Company
    Average 86 stars, based on 1 article reviews
    profenofos pff - by Bioz Stars, 2026-07
    86/100 stars
      Buy from Supplier

    86
    Hasegawa Co Ltd mouse α syn pffs
    LRP1 expression is increased in the nigrostriatal system of a monkey model of PD induced by α-syn <t>PFFs</t> injection. (A) Clinical rating score of monkeys after stereotactic injection of 600 μg of α-syn PFFs or an equal volume of normal saline for 4 months. (B) Immunohistochemistry detection of TH in the STR (left) and SN (right). The TH signal intensity in the STR and the number of TH-positive neurons in the SN were lower in the PFF group. The black arrow heads indicate typical TH-positive neurons. Scale bars: 100 μm. (C) Quantitative immunohistochemistry density analysis of TH in the STR. (D) Quantitation of the ratio of TH-positive neurons in the SN in the PFF group compared with the Sham group. (E) Western blot analysis of TH, LRP1, and α-syn expression levels in the monkey STR. (F–H) Densitometric analysis of TH (F), LRP1 (G), and α-syn (H) expression levels in the STR. (I) Western blot analysis of TH, LRP1, and α-syn expression levels in the monkey SN. (J–L) Densitometric analysis of TH (J), LRP1 (K), and α-syn (L) expression levels in the SN. Data are expressed as mean ± SD ( n = 3). * P < 0.05, ** P < 0.01, *** P < 0.001, vs. Sham group (unpaired t -test). LRP1: Low-density lipoprotein receptor-related protein 1; PD: Parkinson’s disease; PFF: pre-formed fibril; SN: substantia nigra; STR: striatum; TH: tyrosine hydroxylase; α-syn: α-synuclein.
    Mouse α Syn Pffs, supplied by Hasegawa Co Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pff/pm41786869-312-5-11?v=Hasegawa+Co+Ltd
    Average 86 stars, based on 1 article reviews
    mouse α syn pffs - by Bioz Stars, 2026-07
    86/100 stars
      Buy from Supplier

    95
    StressMarq pffs
    Probe P1 shows high labeling accuracy <t>for</t> <t>α-syn</t> aggregates in vitro, compared to phosphorylated (pS129) α-syn antibody which was used as the gold standard reference staining for α-syn aggregates. (a) Structure of peptide-based probe P1 ; (b) Setup of primary hippocampal neuronal culture and induction of α-syn aggregation upon addition of <t>PFFs;</t> (c) Confocal microscopy of primary neuronal cells post 7 days of PFF addition. Nuclei are colored blue, total α-syn green, pS129 α-syn orange, and probe P1 in red. Scale bar represents 200 μm; (d) Probe P1 shows colocalized staining with the PS129 α-syn antibody staining. The probe labels most of the same focal locations, but with slightly larger surrounding area than the PS129 α-syn antibody hitsthis is still regarded as a positive colocalization. True positives (indicated by green arrows) are stained by both P1 and the pS129 α-syn antibody. False negatives (indicated by pink arrows) are not stained by P1 but stained by the pS129 α-syn antibody. Scale bar represents 100 μm; (e) Graph showing average positive predictive value (true positives/probe positives) of 87.4% and miss rate (false negatives/antibody positives) of 8.7%. Values on graph are given as the mean ± SEM calculated over 10 wells, with 9 fields of view each.
    Pffs, supplied by StressMarq, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pff/pmc13003444-207-10-15?v=StressMarq
    Average 95 stars, based on 1 article reviews
    pffs - by Bioz Stars, 2026-07
    95/100 stars
      Buy from Supplier

    93
    StressMarq α syn pff
    Probe P1 shows high labeling accuracy <t>for</t> <t>α-syn</t> aggregates in vitro, compared to phosphorylated (pS129) α-syn antibody which was used as the gold standard reference staining for α-syn aggregates. (a) Structure of peptide-based probe P1 ; (b) Setup of primary hippocampal neuronal culture and induction of α-syn aggregation upon addition of PFFs; (c) Confocal microscopy of primary neuronal cells post 7 days of <t>PFF</t> addition. Nuclei are colored blue, total α-syn green, pS129 α-syn orange, and probe P1 in red. Scale bar represents 200 μm; (d) Probe P1 shows colocalized staining with the PS129 α-syn antibody staining. The probe labels most of the same focal locations, but with slightly larger surrounding area than the PS129 α-syn antibody hitsthis is still regarded as a positive colocalization. True positives (indicated by green arrows) are stained by both P1 and the pS129 α-syn antibody. False negatives (indicated by pink arrows) are not stained by P1 but stained by the pS129 α-syn antibody. Scale bar represents 100 μm; (e) Graph showing average positive predictive value (true positives/probe positives) of 87.4% and miss rate (false negatives/antibody positives) of 8.7%. Values on graph are given as the mean ± SEM calculated over 10 wells, with 9 fields of view each.
    α Syn Pff, supplied by StressMarq, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pff/pmc13003444-234-5-7?v=StressMarq
    Average 93 stars, based on 1 article reviews
    α syn pff - by Bioz Stars, 2026-07
    93/100 stars
      Buy from Supplier

    94
    Novus Biologicals recombinant mouse alpha synuclein pffs
    Probe P1 shows high labeling accuracy <t>for</t> <t>α-syn</t> aggregates in vitro, compared to phosphorylated (pS129) α-syn antibody which was used as the gold standard reference staining for α-syn aggregates. (a) Structure of peptide-based probe P1 ; (b) Setup of primary hippocampal neuronal culture and induction of α-syn aggregation upon addition of PFFs; (c) Confocal microscopy of primary neuronal cells post 7 days of <t>PFF</t> addition. Nuclei are colored blue, total α-syn green, pS129 α-syn orange, and probe P1 in red. Scale bar represents 200 μm; (d) Probe P1 shows colocalized staining with the PS129 α-syn antibody staining. The probe labels most of the same focal locations, but with slightly larger surrounding area than the PS129 α-syn antibody hitsthis is still regarded as a positive colocalization. True positives (indicated by green arrows) are stained by both P1 and the pS129 α-syn antibody. False negatives (indicated by pink arrows) are not stained by P1 but stained by the pS129 α-syn antibody. Scale bar represents 100 μm; (e) Graph showing average positive predictive value (true positives/probe positives) of 87.4% and miss rate (false negatives/antibody positives) of 8.7%. Values on graph are given as the mean ± SEM calculated over 10 wells, with 9 fields of view each.
    Recombinant Mouse Alpha Synuclein Pffs, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pff/pm41730916-264-1-8?v=Novus+Biologicals
    Average 94 stars, based on 1 article reviews
    recombinant mouse alpha synuclein pffs - by Bioz Stars, 2026-07
    94/100 stars
      Buy from Supplier

    94
    Novus Biologicals pre formed fibrils pffs
    Probe P1 shows high labeling accuracy <t>for</t> <t>α-syn</t> aggregates in vitro, compared to phosphorylated (pS129) α-syn antibody which was used as the gold standard reference staining for α-syn aggregates. (a) Structure of peptide-based probe P1 ; (b) Setup of primary hippocampal neuronal culture and induction of α-syn aggregation upon addition of PFFs; (c) Confocal microscopy of primary neuronal cells post 7 days of <t>PFF</t> addition. Nuclei are colored blue, total α-syn green, pS129 α-syn orange, and probe P1 in red. Scale bar represents 200 μm; (d) Probe P1 shows colocalized staining with the PS129 α-syn antibody staining. The probe labels most of the same focal locations, but with slightly larger surrounding area than the PS129 α-syn antibody hitsthis is still regarded as a positive colocalization. True positives (indicated by green arrows) are stained by both P1 and the pS129 α-syn antibody. False negatives (indicated by pink arrows) are not stained by P1 but stained by the pS129 α-syn antibody. Scale bar represents 100 μm; (e) Graph showing average positive predictive value (true positives/probe positives) of 87.4% and miss rate (false negatives/antibody positives) of 8.7%. Values on graph are given as the mean ± SEM calculated over 10 wells, with 9 fields of view each.
    Pre Formed Fibrils Pffs, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pff/pm41730916-262-27-30?v=Novus+Biologicals
    Average 94 stars, based on 1 article reviews
    pre formed fibrils pffs - by Bioz Stars, 2026-07
    94/100 stars
      Buy from Supplier

    Image Search Results


    LRP1 expression is increased in the nigrostriatal system of a monkey model of PD induced by α-syn PFFs injection. (A) Clinical rating score of monkeys after stereotactic injection of 600 μg of α-syn PFFs or an equal volume of normal saline for 4 months. (B) Immunohistochemistry detection of TH in the STR (left) and SN (right). The TH signal intensity in the STR and the number of TH-positive neurons in the SN were lower in the PFF group. The black arrow heads indicate typical TH-positive neurons. Scale bars: 100 μm. (C) Quantitative immunohistochemistry density analysis of TH in the STR. (D) Quantitation of the ratio of TH-positive neurons in the SN in the PFF group compared with the Sham group. (E) Western blot analysis of TH, LRP1, and α-syn expression levels in the monkey STR. (F–H) Densitometric analysis of TH (F), LRP1 (G), and α-syn (H) expression levels in the STR. (I) Western blot analysis of TH, LRP1, and α-syn expression levels in the monkey SN. (J–L) Densitometric analysis of TH (J), LRP1 (K), and α-syn (L) expression levels in the SN. Data are expressed as mean ± SD ( n = 3). * P < 0.05, ** P < 0.01, *** P < 0.001, vs. Sham group (unpaired t -test). LRP1: Low-density lipoprotein receptor-related protein 1; PD: Parkinson’s disease; PFF: pre-formed fibril; SN: substantia nigra; STR: striatum; TH: tyrosine hydroxylase; α-syn: α-synuclein.

    Journal: Neural Regeneration Research

    Article Title: Low-density lipoprotein receptor–related protein 1 mediates α-synuclein transmission from the striatum to the substantia nigra in animal models of Parkinson’s disease

    doi: 10.4103/NRR.NRR-D-23-01965

    Figure Lengend Snippet: LRP1 expression is increased in the nigrostriatal system of a monkey model of PD induced by α-syn PFFs injection. (A) Clinical rating score of monkeys after stereotactic injection of 600 μg of α-syn PFFs or an equal volume of normal saline for 4 months. (B) Immunohistochemistry detection of TH in the STR (left) and SN (right). The TH signal intensity in the STR and the number of TH-positive neurons in the SN were lower in the PFF group. The black arrow heads indicate typical TH-positive neurons. Scale bars: 100 μm. (C) Quantitative immunohistochemistry density analysis of TH in the STR. (D) Quantitation of the ratio of TH-positive neurons in the SN in the PFF group compared with the Sham group. (E) Western blot analysis of TH, LRP1, and α-syn expression levels in the monkey STR. (F–H) Densitometric analysis of TH (F), LRP1 (G), and α-syn (H) expression levels in the STR. (I) Western blot analysis of TH, LRP1, and α-syn expression levels in the monkey SN. (J–L) Densitometric analysis of TH (J), LRP1 (K), and α-syn (L) expression levels in the SN. Data are expressed as mean ± SD ( n = 3). * P < 0.05, ** P < 0.01, *** P < 0.001, vs. Sham group (unpaired t -test). LRP1: Low-density lipoprotein receptor-related protein 1; PD: Parkinson’s disease; PFF: pre-formed fibril; SN: substantia nigra; STR: striatum; TH: tyrosine hydroxylase; α-syn: α-synuclein.

    Article Snippet: α-Syn PFFs (SPR-322, StressMarq, Victoria, Canada) were sonicated with a handheld probe (VCX130, SONICS & MATERIALS, Newtown, CT, USA) as follows: amplitude 30% and time 15 seconds (pulse on 3 seconds, pulse off 6 seconds) (Volpicelli-Daley et al., 2014; Sun et al., 2022b).

    Techniques: Expressing, Injection, Saline, Immunohistochemistry, Quantitation Assay, Western Blot

    LRP1 expression is increased in the nigrostriatal system of a mouse model of PD induced by injection with α-Syn PFFs. (A) Visual gait analysis of walking, gait, and footprint pressure in mice after stereotactic injection with 5 μg of α-Syn PFFs or an equal volume of PBS for 4 weeks ( n = 6). (B) Normal step sequence in mice ( n = 6). (C) Average speed in mice ( n = 6). (D) Tripod support time in mice ( n = 6). (E) Immunohistochemistry staining for TH in the STR. The images in the second row are enlarged images of the areas indicated in black boxes in the upper row. The TH signal intensity in the STR was lower in the PFF group. Scale bars: 200 μm, 40 μm (enlarged). (F) Immunohistochemistry staining for TH in the SN. The images in the second row are enlarged images of the areas indicated in black boxes in the upper row, and the white arrowheads indicate typical TH-positive neurons. There were fewer TH-positive neurons in the SN in the PFF group. Scale bars: 100 μm, 20 μm (enlarged). (G) Quantitative immunohistochemistry density analysis of TH in the STR, compared with the Sham group ( n = 3). (H) Quantitation of the ratio of TH-positive neurons in the SN in the PFF group compared with the Sham group ( n = 3). (I) Western blot analysis of TH, LRP1, and α-Syn expression levels in the mouse STR after injection with 5 μg of α-Syn PFFs or an equal volume of PBS ( n = 3). (J–L) Densitometric analysis of TH (J), LRP1 (K), and α-Syn (L) expression levels in the STR. (M) Western blot analysis of TH, LRP1, and α-Syn expression levels in the mouse SN ( n = 3). (N–P) Densitometric analysis of TH (N), LRP1 (O), and α-Syn (P) expression levels in the SN ( n = 3). Data are expressed as mean ± SD ( n = 3). * P < 0.05, ** P < 0.01, *** P < 0.001, vs . Sham group (unpaired t -test). LRP1: Low-density lipoprotein receptor-related protein 1; PBS: phosphate buffered solution; PD: Parkinson’s disease; PFF: pre-formed fibril; SN: substantia nigra; STR: striatum; TH: tyrosine hydroxylase; α-Syn: α-synuclein.

    Journal: Neural Regeneration Research

    Article Title: Low-density lipoprotein receptor–related protein 1 mediates α-synuclein transmission from the striatum to the substantia nigra in animal models of Parkinson’s disease

    doi: 10.4103/NRR.NRR-D-23-01965

    Figure Lengend Snippet: LRP1 expression is increased in the nigrostriatal system of a mouse model of PD induced by injection with α-Syn PFFs. (A) Visual gait analysis of walking, gait, and footprint pressure in mice after stereotactic injection with 5 μg of α-Syn PFFs or an equal volume of PBS for 4 weeks ( n = 6). (B) Normal step sequence in mice ( n = 6). (C) Average speed in mice ( n = 6). (D) Tripod support time in mice ( n = 6). (E) Immunohistochemistry staining for TH in the STR. The images in the second row are enlarged images of the areas indicated in black boxes in the upper row. The TH signal intensity in the STR was lower in the PFF group. Scale bars: 200 μm, 40 μm (enlarged). (F) Immunohistochemistry staining for TH in the SN. The images in the second row are enlarged images of the areas indicated in black boxes in the upper row, and the white arrowheads indicate typical TH-positive neurons. There were fewer TH-positive neurons in the SN in the PFF group. Scale bars: 100 μm, 20 μm (enlarged). (G) Quantitative immunohistochemistry density analysis of TH in the STR, compared with the Sham group ( n = 3). (H) Quantitation of the ratio of TH-positive neurons in the SN in the PFF group compared with the Sham group ( n = 3). (I) Western blot analysis of TH, LRP1, and α-Syn expression levels in the mouse STR after injection with 5 μg of α-Syn PFFs or an equal volume of PBS ( n = 3). (J–L) Densitometric analysis of TH (J), LRP1 (K), and α-Syn (L) expression levels in the STR. (M) Western blot analysis of TH, LRP1, and α-Syn expression levels in the mouse SN ( n = 3). (N–P) Densitometric analysis of TH (N), LRP1 (O), and α-Syn (P) expression levels in the SN ( n = 3). Data are expressed as mean ± SD ( n = 3). * P < 0.05, ** P < 0.01, *** P < 0.001, vs . Sham group (unpaired t -test). LRP1: Low-density lipoprotein receptor-related protein 1; PBS: phosphate buffered solution; PD: Parkinson’s disease; PFF: pre-formed fibril; SN: substantia nigra; STR: striatum; TH: tyrosine hydroxylase; α-Syn: α-synuclein.

    Article Snippet: α-Syn PFFs (SPR-322, StressMarq, Victoria, Canada) were sonicated with a handheld probe (VCX130, SONICS & MATERIALS, Newtown, CT, USA) as follows: amplitude 30% and time 15 seconds (pulse on 3 seconds, pulse off 6 seconds) (Volpicelli-Daley et al., 2014; Sun et al., 2022b).

    Techniques: Expressing, Injection, Sequencing, Immunohistochemistry, Staining, Quantitation Assay, Western Blot

    Exogenous α-syn PFFs upregulate LRP1 expression in PC12 cells. (A) Viability of PC12 cells incubated with different doses (0, 5, 10, 20, or 50 µg/mL) of α-Syn PFFs for 24 hours. ** P < 0.01, *** P < 0.001, vs . 0 µg/mL group. (B) Western blot analysis of LRP1 and α-syn expression levels in PC12 cells. (C, D) Densitometric analysis of LRP1 (C) and α-syn (D) expression levels. (E) Immunofluorescence analysis of LRP1 (green, Alexa Fluor 488), α-syn (red, Alexa Fluor 594), and DAPI (blue) expression. The LRP1 and α-syn signal intensities were stronger in PFF group than in Con group. Scale bars: 40 μm. (F, G) Quantitative immunofluorescence intensity analysis of LRP1 (F) and α-syn (G). * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001, vs . Con group; # P < 0.05, ## P < 0.01, vs. monomer group. Data are expressed as mean ± SD ( n = 3). Con: Control; DAPI: 4′,6-diamidino-2-phenylindole; PFF: pre-formed fibril; LRP1: low-density lipoprotein receptor-related protein 1; α-syn: α-synuclein.

    Journal: Neural Regeneration Research

    Article Title: Low-density lipoprotein receptor–related protein 1 mediates α-synuclein transmission from the striatum to the substantia nigra in animal models of Parkinson’s disease

    doi: 10.4103/NRR.NRR-D-23-01965

    Figure Lengend Snippet: Exogenous α-syn PFFs upregulate LRP1 expression in PC12 cells. (A) Viability of PC12 cells incubated with different doses (0, 5, 10, 20, or 50 µg/mL) of α-Syn PFFs for 24 hours. ** P < 0.01, *** P < 0.001, vs . 0 µg/mL group. (B) Western blot analysis of LRP1 and α-syn expression levels in PC12 cells. (C, D) Densitometric analysis of LRP1 (C) and α-syn (D) expression levels. (E) Immunofluorescence analysis of LRP1 (green, Alexa Fluor 488), α-syn (red, Alexa Fluor 594), and DAPI (blue) expression. The LRP1 and α-syn signal intensities were stronger in PFF group than in Con group. Scale bars: 40 μm. (F, G) Quantitative immunofluorescence intensity analysis of LRP1 (F) and α-syn (G). * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001, vs . Con group; # P < 0.05, ## P < 0.01, vs. monomer group. Data are expressed as mean ± SD ( n = 3). Con: Control; DAPI: 4′,6-diamidino-2-phenylindole; PFF: pre-formed fibril; LRP1: low-density lipoprotein receptor-related protein 1; α-syn: α-synuclein.

    Article Snippet: α-Syn PFFs (SPR-322, StressMarq, Victoria, Canada) were sonicated with a handheld probe (VCX130, SONICS & MATERIALS, Newtown, CT, USA) as follows: amplitude 30% and time 15 seconds (pulse on 3 seconds, pulse off 6 seconds) (Volpicelli-Daley et al., 2014; Sun et al., 2022b).

    Techniques: Expressing, Incubation, Western Blot, Immunofluorescence, Control

    LRP1 knockdown rescues the dopaminergic damage induced by exogenous α-syn PFFs. (A, B) Western blot analysis (A) and densitometric analysis (B) of TH expression levels in the STR of mice treated with PFFs. (C, D) Western blot analysis (C) and densitometric analysis (D) of TH expression levels in the SN of mice treated with PFFs. (E) Immunohistochemistry staining for TH in the STR of mice treated with PFFs and LRP1 siRNA. The decrease in relative TH intensity in STR observed in the PFF group was rescued by LRP1 siRNA treatment. The images in the second row are enlarged images of the areas indicated by black boxes in the upper row. Scale bars: 200 μm, 40 μm (enlarged). (F) Quantitative immunohistochemistry density analysis of TH in the STR. (G) Immunohistochemistry analysis of TH in the SN of mice treated with PFFs. The decreased ratio of TH-positive neurons in the SN of the Scramble + PFF group (PFF group) was rescued by LRP1 siRNA treatment. The images in the second row are enlarged images of the areas indicated by black boxes in the upper row, and the white arrowheads indicate typical TH-positive neurons. Scale bars: 100 μm, 20 μm (enlarged). (H) Quantitation of the ratio of TH-positive neurons in the SN compared with the PBS group. Data are expressed as mean ± SD ( n = 3). * P < 0.05, ** P < 0.01, *** P < 0.001, vs. Scramble + PBS group (PBS group); # P < 0.05, ## P < 0.01, vs. scramble + PFF group (PFF group). LRP1: Low-density lipoprotein receptor-related protein 1; PBS: phosphate buffered solution; PFF: pre-formed fibril; siRNA: small interfering RNA; SN: substantia nigra; STR: striatum; TH: tyrosine hydroxylase; α-syn: α-synuclein.

    Journal: Neural Regeneration Research

    Article Title: Low-density lipoprotein receptor–related protein 1 mediates α-synuclein transmission from the striatum to the substantia nigra in animal models of Parkinson’s disease

    doi: 10.4103/NRR.NRR-D-23-01965

    Figure Lengend Snippet: LRP1 knockdown rescues the dopaminergic damage induced by exogenous α-syn PFFs. (A, B) Western blot analysis (A) and densitometric analysis (B) of TH expression levels in the STR of mice treated with PFFs. (C, D) Western blot analysis (C) and densitometric analysis (D) of TH expression levels in the SN of mice treated with PFFs. (E) Immunohistochemistry staining for TH in the STR of mice treated with PFFs and LRP1 siRNA. The decrease in relative TH intensity in STR observed in the PFF group was rescued by LRP1 siRNA treatment. The images in the second row are enlarged images of the areas indicated by black boxes in the upper row. Scale bars: 200 μm, 40 μm (enlarged). (F) Quantitative immunohistochemistry density analysis of TH in the STR. (G) Immunohistochemistry analysis of TH in the SN of mice treated with PFFs. The decreased ratio of TH-positive neurons in the SN of the Scramble + PFF group (PFF group) was rescued by LRP1 siRNA treatment. The images in the second row are enlarged images of the areas indicated by black boxes in the upper row, and the white arrowheads indicate typical TH-positive neurons. Scale bars: 100 μm, 20 μm (enlarged). (H) Quantitation of the ratio of TH-positive neurons in the SN compared with the PBS group. Data are expressed as mean ± SD ( n = 3). * P < 0.05, ** P < 0.01, *** P < 0.001, vs. Scramble + PBS group (PBS group); # P < 0.05, ## P < 0.01, vs. scramble + PFF group (PFF group). LRP1: Low-density lipoprotein receptor-related protein 1; PBS: phosphate buffered solution; PFF: pre-formed fibril; siRNA: small interfering RNA; SN: substantia nigra; STR: striatum; TH: tyrosine hydroxylase; α-syn: α-synuclein.

    Article Snippet: α-Syn PFFs (SPR-322, StressMarq, Victoria, Canada) were sonicated with a handheld probe (VCX130, SONICS & MATERIALS, Newtown, CT, USA) as follows: amplitude 30% and time 15 seconds (pulse on 3 seconds, pulse off 6 seconds) (Volpicelli-Daley et al., 2014; Sun et al., 2022b).

    Techniques: Knockdown, Western Blot, Expressing, Immunohistochemistry, Staining, Quantitation Assay, Small Interfering RNA

    LRP1 suppression reduces the transmission of exogenous α-syn in vivo . (A) Immunofluorescence staining for LRP1 (green, Alexa Fluor 488), α-syn (red, Alexa Fluor 594), and DAPI (blue) in the mouse STR after stereotactic injection with α-syn PFFs for 6 weeks with or without LRP1 knockdown. The increase in the relative fluorescence intensity of LRP1 and α-syn in the STR of PFFs-treated mice was rescued by LRP1 siRNA treatment. Scale bars: 100 μm. (B, C) Quantitative immunofluorescence intensity of LRP1 (B) and α-syn (C) in mouse STR. (D) Immunofluorescence staining for LRP1 (green, Alexa Fluor 488), α-syn (red, Alexa Fluor 594), and DAPI (blue) in the SN of mice after stereotactic injection with α-syn PFFs for 6 weeks with or without LRP1 knockdown. The increase in the relative fluorescence intensity of LRP1 and α-syn in the SN of mice treated with PFFs was rescued by LRP1 siRNA treatment. The white arrowheads indicate typical cells exhibiting α-syn and LRP1 expression. Scale bars: 100 μm. (E, F) Quantitative immunofluorescence intensity of LRP1 (E) and α-syn (F) in the mouse SN. (G) Western blot analysis of LRP1 and α-syn expression levels in the mouse STR. (H, I) Densitometric analysis of LRP1 (H) and α-syn (I) expression levels in the mouse STR. (J) Western blot analysis of LRP1 and α-syn expression levels in the mouse SN. (K, L) Densitometric analysis of LRP1 (K) and α-syn (L) expression levels in the mouse SN. Data are expressed as mean ± SD ( n = 3). * P < 0.05, ** P < 0.01, vs. Scramble + PBS group (PBS group); # P < 0.05, ## P < 0.01, vs . Scramble + PFF group (PFF group). DAPI: 4′,6-Diamidino-2-phenylindole; LRP1: low-density lipoprotein receptor-related protein 1; PBS: phosphate buffered solution; PFF: pre-formed fibril; siRNA: small interfering RNA; SN: substantia nigra; STR: striatum; α-syn: α-synuclein.

    Journal: Neural Regeneration Research

    Article Title: Low-density lipoprotein receptor–related protein 1 mediates α-synuclein transmission from the striatum to the substantia nigra in animal models of Parkinson’s disease

    doi: 10.4103/NRR.NRR-D-23-01965

    Figure Lengend Snippet: LRP1 suppression reduces the transmission of exogenous α-syn in vivo . (A) Immunofluorescence staining for LRP1 (green, Alexa Fluor 488), α-syn (red, Alexa Fluor 594), and DAPI (blue) in the mouse STR after stereotactic injection with α-syn PFFs for 6 weeks with or without LRP1 knockdown. The increase in the relative fluorescence intensity of LRP1 and α-syn in the STR of PFFs-treated mice was rescued by LRP1 siRNA treatment. Scale bars: 100 μm. (B, C) Quantitative immunofluorescence intensity of LRP1 (B) and α-syn (C) in mouse STR. (D) Immunofluorescence staining for LRP1 (green, Alexa Fluor 488), α-syn (red, Alexa Fluor 594), and DAPI (blue) in the SN of mice after stereotactic injection with α-syn PFFs for 6 weeks with or without LRP1 knockdown. The increase in the relative fluorescence intensity of LRP1 and α-syn in the SN of mice treated with PFFs was rescued by LRP1 siRNA treatment. The white arrowheads indicate typical cells exhibiting α-syn and LRP1 expression. Scale bars: 100 μm. (E, F) Quantitative immunofluorescence intensity of LRP1 (E) and α-syn (F) in the mouse SN. (G) Western blot analysis of LRP1 and α-syn expression levels in the mouse STR. (H, I) Densitometric analysis of LRP1 (H) and α-syn (I) expression levels in the mouse STR. (J) Western blot analysis of LRP1 and α-syn expression levels in the mouse SN. (K, L) Densitometric analysis of LRP1 (K) and α-syn (L) expression levels in the mouse SN. Data are expressed as mean ± SD ( n = 3). * P < 0.05, ** P < 0.01, vs. Scramble + PBS group (PBS group); # P < 0.05, ## P < 0.01, vs . Scramble + PFF group (PFF group). DAPI: 4′,6-Diamidino-2-phenylindole; LRP1: low-density lipoprotein receptor-related protein 1; PBS: phosphate buffered solution; PFF: pre-formed fibril; siRNA: small interfering RNA; SN: substantia nigra; STR: striatum; α-syn: α-synuclein.

    Article Snippet: α-Syn PFFs (SPR-322, StressMarq, Victoria, Canada) were sonicated with a handheld probe (VCX130, SONICS & MATERIALS, Newtown, CT, USA) as follows: amplitude 30% and time 15 seconds (pulse on 3 seconds, pulse off 6 seconds) (Volpicelli-Daley et al., 2014; Sun et al., 2022b).

    Techniques: Transmission Assay, In Vivo, Immunofluorescence, Staining, Injection, Knockdown, Fluorescence, Expressing, Western Blot, Small Interfering RNA

    LRP1 mediates the uptake of α-syn PFFs by PC12 cells. (A) Western blot analysis of LRP1 and α-syn expression levels in PC12 cells with or without LRP1 knockdown (10 nM siRNA) after incubation with 10 µg/mL α-syn PFFs for 24 hours. (B, C) Densitometric analysis of LRP1 (B) and α-syn (C) expression. (D) Immunofluorescence staining for LRP1 (green, Alexa Fluor 488), α-syn (red, Alexa Fluor 594), and DAPI (blue). The increase in the relative fluorescence intensity levels of LRP1 and α-syn in the PFF group was rescued by LRP1 siRNA treatment. Scale bars: 40 μm. (E, F) Quantitative immunofluorescence intensity analysis of LRP1 (E) and α-syn (F). Data are expressed as mean ± SD ( n = 3). ** P < 0.01, *** P < 0.001, **** P < 0.0001, vs . Con group; # P < 0.05, ## P < 0.01, #### P < 0.0001, vs . PFF/– group. Con: Control; DAPI: 4′, 6-diamidino-2-phenylindole; PFF: pre-formed fibril; LRP1: low-density lipoprotein receptor-related protein 1; siRNA: small interfering RNA; α-syn: α-synuclein.

    Journal: Neural Regeneration Research

    Article Title: Low-density lipoprotein receptor–related protein 1 mediates α-synuclein transmission from the striatum to the substantia nigra in animal models of Parkinson’s disease

    doi: 10.4103/NRR.NRR-D-23-01965

    Figure Lengend Snippet: LRP1 mediates the uptake of α-syn PFFs by PC12 cells. (A) Western blot analysis of LRP1 and α-syn expression levels in PC12 cells with or without LRP1 knockdown (10 nM siRNA) after incubation with 10 µg/mL α-syn PFFs for 24 hours. (B, C) Densitometric analysis of LRP1 (B) and α-syn (C) expression. (D) Immunofluorescence staining for LRP1 (green, Alexa Fluor 488), α-syn (red, Alexa Fluor 594), and DAPI (blue). The increase in the relative fluorescence intensity levels of LRP1 and α-syn in the PFF group was rescued by LRP1 siRNA treatment. Scale bars: 40 μm. (E, F) Quantitative immunofluorescence intensity analysis of LRP1 (E) and α-syn (F). Data are expressed as mean ± SD ( n = 3). ** P < 0.01, *** P < 0.001, **** P < 0.0001, vs . Con group; # P < 0.05, ## P < 0.01, #### P < 0.0001, vs . PFF/– group. Con: Control; DAPI: 4′, 6-diamidino-2-phenylindole; PFF: pre-formed fibril; LRP1: low-density lipoprotein receptor-related protein 1; siRNA: small interfering RNA; α-syn: α-synuclein.

    Article Snippet: α-Syn PFFs (SPR-322, StressMarq, Victoria, Canada) were sonicated with a handheld probe (VCX130, SONICS & MATERIALS, Newtown, CT, USA) as follows: amplitude 30% and time 15 seconds (pulse on 3 seconds, pulse off 6 seconds) (Volpicelli-Daley et al., 2014; Sun et al., 2022b).

    Techniques: Western Blot, Expressing, Knockdown, Incubation, Immunofluorescence, Staining, Fluorescence, Control, Small Interfering RNA

    Lysine residues in the α-syn N-terminus are vital for LRP1-mediated α-Syn internalization. (A) Heatmap of amino acids in different α-syn domains. (B) Western blot analysis of LRP1 and α-Syn levels in PC12 cells after addition of α-syn PFFs (10 µg/mL) with or without capping of lysine residues for 24 hours. (C, D) Densitometric analysis of LRP1 (C) and α-syn (D) expression levels. (E) Immunofluorescence staining for LRP1 (green, Alexa Fluor 488), α-Syn (red, Alexa Fluor 594), and DAPI (blue). The increase in the relative fluorescence intensity of LRP1 and α-syn in the PFF group was rescued by lysine capping of α-syn. Scale bars: 40 μm. (F, G) Quantitative immunofluorescence intensity analysis of LRP1 (F) and α-syn (G). Data are expressed as mean ± SD ( n = 3). * P < 0.05, ** P < 0.01, **** P < 0.0001, vs. Con group; # P < 0.05, ## P < 0.01, vs . PFF group. Con: Control; DAPI: 4′,6-diamidino-2-phenylindole; LRP1: low-density lipoprotein receptor-related protein 1; NHS: sulfo-NHS acetate; PFF: pre-formed fibril; α-syn: α-synuclein.

    Journal: Neural Regeneration Research

    Article Title: Low-density lipoprotein receptor–related protein 1 mediates α-synuclein transmission from the striatum to the substantia nigra in animal models of Parkinson’s disease

    doi: 10.4103/NRR.NRR-D-23-01965

    Figure Lengend Snippet: Lysine residues in the α-syn N-terminus are vital for LRP1-mediated α-Syn internalization. (A) Heatmap of amino acids in different α-syn domains. (B) Western blot analysis of LRP1 and α-Syn levels in PC12 cells after addition of α-syn PFFs (10 µg/mL) with or without capping of lysine residues for 24 hours. (C, D) Densitometric analysis of LRP1 (C) and α-syn (D) expression levels. (E) Immunofluorescence staining for LRP1 (green, Alexa Fluor 488), α-Syn (red, Alexa Fluor 594), and DAPI (blue). The increase in the relative fluorescence intensity of LRP1 and α-syn in the PFF group was rescued by lysine capping of α-syn. Scale bars: 40 μm. (F, G) Quantitative immunofluorescence intensity analysis of LRP1 (F) and α-syn (G). Data are expressed as mean ± SD ( n = 3). * P < 0.05, ** P < 0.01, **** P < 0.0001, vs. Con group; # P < 0.05, ## P < 0.01, vs . PFF group. Con: Control; DAPI: 4′,6-diamidino-2-phenylindole; LRP1: low-density lipoprotein receptor-related protein 1; NHS: sulfo-NHS acetate; PFF: pre-formed fibril; α-syn: α-synuclein.

    Article Snippet: α-Syn PFFs (SPR-322, StressMarq, Victoria, Canada) were sonicated with a handheld probe (VCX130, SONICS & MATERIALS, Newtown, CT, USA) as follows: amplitude 30% and time 15 seconds (pulse on 3 seconds, pulse off 6 seconds) (Volpicelli-Daley et al., 2014; Sun et al., 2022b).

    Techniques: Western Blot, Expressing, Immunofluorescence, Staining, Fluorescence, Control

    Probe P1 shows high labeling accuracy for α-syn aggregates in vitro, compared to phosphorylated (pS129) α-syn antibody which was used as the gold standard reference staining for α-syn aggregates. (a) Structure of peptide-based probe P1 ; (b) Setup of primary hippocampal neuronal culture and induction of α-syn aggregation upon addition of PFFs; (c) Confocal microscopy of primary neuronal cells post 7 days of PFF addition. Nuclei are colored blue, total α-syn green, pS129 α-syn orange, and probe P1 in red. Scale bar represents 200 μm; (d) Probe P1 shows colocalized staining with the PS129 α-syn antibody staining. The probe labels most of the same focal locations, but with slightly larger surrounding area than the PS129 α-syn antibody hitsthis is still regarded as a positive colocalization. True positives (indicated by green arrows) are stained by both P1 and the pS129 α-syn antibody. False negatives (indicated by pink arrows) are not stained by P1 but stained by the pS129 α-syn antibody. Scale bar represents 100 μm; (e) Graph showing average positive predictive value (true positives/probe positives) of 87.4% and miss rate (false negatives/antibody positives) of 8.7%. Values on graph are given as the mean ± SEM calculated over 10 wells, with 9 fields of view each.

    Journal: ACS Chemical Neuroscience

    Article Title: Fluorescence Detection of Alpha-Synuclein Aggregates in the Gut Using a Peptide Probe

    doi: 10.1021/acschemneuro.6c00069

    Figure Lengend Snippet: Probe P1 shows high labeling accuracy for α-syn aggregates in vitro, compared to phosphorylated (pS129) α-syn antibody which was used as the gold standard reference staining for α-syn aggregates. (a) Structure of peptide-based probe P1 ; (b) Setup of primary hippocampal neuronal culture and induction of α-syn aggregation upon addition of PFFs; (c) Confocal microscopy of primary neuronal cells post 7 days of PFF addition. Nuclei are colored blue, total α-syn green, pS129 α-syn orange, and probe P1 in red. Scale bar represents 200 μm; (d) Probe P1 shows colocalized staining with the PS129 α-syn antibody staining. The probe labels most of the same focal locations, but with slightly larger surrounding area than the PS129 α-syn antibody hitsthis is still regarded as a positive colocalization. True positives (indicated by green arrows) are stained by both P1 and the pS129 α-syn antibody. False negatives (indicated by pink arrows) are not stained by P1 but stained by the pS129 α-syn antibody. Scale bar represents 100 μm; (e) Graph showing average positive predictive value (true positives/probe positives) of 87.4% and miss rate (false negatives/antibody positives) of 8.7%. Values on graph are given as the mean ± SEM calculated over 10 wells, with 9 fields of view each.

    Article Snippet: Human recombinant α-syn monomers (SPR-321C), kinetically stable oligomers (SPR-484C), and PFFs (SPR-322C) were purchased from StressMarq Biosciences and used without further modification.

    Techniques: Labeling, In Vitro, Staining, Confocal Microscopy

    Probe P1 exhibits preferential binding to α-syn fibrils over α-syn monomers. (a) Fluorescent excitation and (b) fluorescent emission spectra of P1 . 2 μM probe P1 was incubated with 10 μM of various α-syn species, including monomers, A* oligomers, B* oligomers, and PFFs. Concentrations of all α-syn species are expressed at their equivalent monomer concentration. Fluorescence intensity of P1 increases significantly upon interaction with PFFs (7.6× and 16× for excitation and emission respectively); (c) Fluorescence titration curve of P1 (0.5 μM) to PFFs, showing micromolar K D ; (d) Native-PAGE images of P1 with various α-syn species, showing that P1 preferentially binds to B* oligomers and PFFs, over α-syn monomers and A* oligomers. 2 μg of P1 was incubated with 2 μg of α-syn monomers and various α-syn aggregate species and run under native PAGE conditions. In-gel fluorescence was first visualized in the 647 channel, and then the gel was subsequently imaged in the brightfield channel after staining with Coomassie blue. Red bands correspond to P1 bound to the B* oligomers and PFFs; (e) Dot-blot images of P1 (0.5 μM) with various human α-syn species, showing concentration-dependent labeling of kinetically stable oligomers and PFFs.

    Journal: ACS Chemical Neuroscience

    Article Title: Fluorescence Detection of Alpha-Synuclein Aggregates in the Gut Using a Peptide Probe

    doi: 10.1021/acschemneuro.6c00069

    Figure Lengend Snippet: Probe P1 exhibits preferential binding to α-syn fibrils over α-syn monomers. (a) Fluorescent excitation and (b) fluorescent emission spectra of P1 . 2 μM probe P1 was incubated with 10 μM of various α-syn species, including monomers, A* oligomers, B* oligomers, and PFFs. Concentrations of all α-syn species are expressed at their equivalent monomer concentration. Fluorescence intensity of P1 increases significantly upon interaction with PFFs (7.6× and 16× for excitation and emission respectively); (c) Fluorescence titration curve of P1 (0.5 μM) to PFFs, showing micromolar K D ; (d) Native-PAGE images of P1 with various α-syn species, showing that P1 preferentially binds to B* oligomers and PFFs, over α-syn monomers and A* oligomers. 2 μg of P1 was incubated with 2 μg of α-syn monomers and various α-syn aggregate species and run under native PAGE conditions. In-gel fluorescence was first visualized in the 647 channel, and then the gel was subsequently imaged in the brightfield channel after staining with Coomassie blue. Red bands correspond to P1 bound to the B* oligomers and PFFs; (e) Dot-blot images of P1 (0.5 μM) with various human α-syn species, showing concentration-dependent labeling of kinetically stable oligomers and PFFs.

    Article Snippet: Human recombinant α-syn monomers (SPR-321C), kinetically stable oligomers (SPR-484C), and PFFs (SPR-322C) were purchased from StressMarq Biosciences and used without further modification.

    Techniques: Binding Assay, Incubation, Concentration Assay, Fluorescence, Titration, Clear Native PAGE, Staining, Dot Blot, Labeling

    Probe P1 shows high labeling accuracy for α-syn aggregates in vitro, compared to phosphorylated (pS129) α-syn antibody which was used as the gold standard reference staining for α-syn aggregates. (a) Structure of peptide-based probe P1 ; (b) Setup of primary hippocampal neuronal culture and induction of α-syn aggregation upon addition of PFFs; (c) Confocal microscopy of primary neuronal cells post 7 days of PFF addition. Nuclei are colored blue, total α-syn green, pS129 α-syn orange, and probe P1 in red. Scale bar represents 200 μm; (d) Probe P1 shows colocalized staining with the PS129 α-syn antibody staining. The probe labels most of the same focal locations, but with slightly larger surrounding area than the PS129 α-syn antibody hitsthis is still regarded as a positive colocalization. True positives (indicated by green arrows) are stained by both P1 and the pS129 α-syn antibody. False negatives (indicated by pink arrows) are not stained by P1 but stained by the pS129 α-syn antibody. Scale bar represents 100 μm; (e) Graph showing average positive predictive value (true positives/probe positives) of 87.4% and miss rate (false negatives/antibody positives) of 8.7%. Values on graph are given as the mean ± SEM calculated over 10 wells, with 9 fields of view each.

    Journal: ACS Chemical Neuroscience

    Article Title: Fluorescence Detection of Alpha-Synuclein Aggregates in the Gut Using a Peptide Probe

    doi: 10.1021/acschemneuro.6c00069

    Figure Lengend Snippet: Probe P1 shows high labeling accuracy for α-syn aggregates in vitro, compared to phosphorylated (pS129) α-syn antibody which was used as the gold standard reference staining for α-syn aggregates. (a) Structure of peptide-based probe P1 ; (b) Setup of primary hippocampal neuronal culture and induction of α-syn aggregation upon addition of PFFs; (c) Confocal microscopy of primary neuronal cells post 7 days of PFF addition. Nuclei are colored blue, total α-syn green, pS129 α-syn orange, and probe P1 in red. Scale bar represents 200 μm; (d) Probe P1 shows colocalized staining with the PS129 α-syn antibody staining. The probe labels most of the same focal locations, but with slightly larger surrounding area than the PS129 α-syn antibody hitsthis is still regarded as a positive colocalization. True positives (indicated by green arrows) are stained by both P1 and the pS129 α-syn antibody. False negatives (indicated by pink arrows) are not stained by P1 but stained by the pS129 α-syn antibody. Scale bar represents 100 μm; (e) Graph showing average positive predictive value (true positives/probe positives) of 87.4% and miss rate (false negatives/antibody positives) of 8.7%. Values on graph are given as the mean ± SEM calculated over 10 wells, with 9 fields of view each.

    Article Snippet: 15 μL of 2 mg/mL α-syn PFF (StressMarq SPR-324) were sonicated in an ultrasonic bath sonicator for 2.5 h at the following conditions: sweep, 37 Hz frequency, 60% power.

    Techniques: Labeling, In Vitro, Staining, Confocal Microscopy

    Probe P1 exhibits preferential binding to α-syn fibrils over α-syn monomers. (a) Fluorescent excitation and (b) fluorescent emission spectra of P1 . 2 μM probe P1 was incubated with 10 μM of various α-syn species, including monomers, A* oligomers, B* oligomers, and PFFs. Concentrations of all α-syn species are expressed at their equivalent monomer concentration. Fluorescence intensity of P1 increases significantly upon interaction with PFFs (7.6× and 16× for excitation and emission respectively); (c) Fluorescence titration curve of P1 (0.5 μM) to PFFs, showing micromolar K D ; (d) Native-PAGE images of P1 with various α-syn species, showing that P1 preferentially binds to B* oligomers and PFFs, over α-syn monomers and A* oligomers. 2 μg of P1 was incubated with 2 μg of α-syn monomers and various α-syn aggregate species and run under native PAGE conditions. In-gel fluorescence was first visualized in the 647 channel, and then the gel was subsequently imaged in the brightfield channel after staining with Coomassie blue. Red bands correspond to P1 bound to the B* oligomers and PFFs; (e) Dot-blot images of P1 (0.5 μM) with various human α-syn species, showing concentration-dependent labeling of kinetically stable oligomers and PFFs.

    Journal: ACS Chemical Neuroscience

    Article Title: Fluorescence Detection of Alpha-Synuclein Aggregates in the Gut Using a Peptide Probe

    doi: 10.1021/acschemneuro.6c00069

    Figure Lengend Snippet: Probe P1 exhibits preferential binding to α-syn fibrils over α-syn monomers. (a) Fluorescent excitation and (b) fluorescent emission spectra of P1 . 2 μM probe P1 was incubated with 10 μM of various α-syn species, including monomers, A* oligomers, B* oligomers, and PFFs. Concentrations of all α-syn species are expressed at their equivalent monomer concentration. Fluorescence intensity of P1 increases significantly upon interaction with PFFs (7.6× and 16× for excitation and emission respectively); (c) Fluorescence titration curve of P1 (0.5 μM) to PFFs, showing micromolar K D ; (d) Native-PAGE images of P1 with various α-syn species, showing that P1 preferentially binds to B* oligomers and PFFs, over α-syn monomers and A* oligomers. 2 μg of P1 was incubated with 2 μg of α-syn monomers and various α-syn aggregate species and run under native PAGE conditions. In-gel fluorescence was first visualized in the 647 channel, and then the gel was subsequently imaged in the brightfield channel after staining with Coomassie blue. Red bands correspond to P1 bound to the B* oligomers and PFFs; (e) Dot-blot images of P1 (0.5 μM) with various human α-syn species, showing concentration-dependent labeling of kinetically stable oligomers and PFFs.

    Article Snippet: 15 μL of 2 mg/mL α-syn PFF (StressMarq SPR-324) were sonicated in an ultrasonic bath sonicator for 2.5 h at the following conditions: sweep, 37 Hz frequency, 60% power.

    Techniques: Binding Assay, Incubation, Concentration Assay, Fluorescence, Titration, Clear Native PAGE, Staining, Dot Blot, Labeling

    Probe P1 shows specific staining of α-syn aggregates in tissues from PFF-injected mouse models. (a) Models used for ex vivo tissue labeling: PFF-injected mouse (C57BL6), where PFF was injected directly into the brain or duodenum, and transgenic mouse models overexpressing human α-syn; (b) Confocal microscopy of brain tissues after 30 days of PFF injection showing high levels of α-syn aggregation in the hippocampal and cortex regions, labeled specifically by both pS129 α-syn antibody and P1 ; (c) Confocal microscopy of duodenum tissues after 75 days of PFF injection showing low levels of α-syn aggregation in the mucosa region indicated by the white arrows. Images of tissues from control PBS-injected mice are shown in Figure S5 for comparison; (d) Confocal microscopy of brain tissue (substantia nigra) of a healthy control and of a PD patient (post-mortem), with pS129 α-syn antibody staining and P1 staining observed in the substantia nigra of the PD patient; (e) Confocal microscopy showing Lewy bodies (LB) and Lewy neurites (LN) highlighted by pS129 α-syn antibody staining in the substantia nigra of a PD patient. Higher magnification images of LB and LN show specific labeling by P1 that corresponds to the antibody staining. Nuclei in blue, α-syn in green, pS129 α-syn in orange and probe P1 in red.

    Journal: ACS Chemical Neuroscience

    Article Title: Fluorescence Detection of Alpha-Synuclein Aggregates in the Gut Using a Peptide Probe

    doi: 10.1021/acschemneuro.6c00069

    Figure Lengend Snippet: Probe P1 shows specific staining of α-syn aggregates in tissues from PFF-injected mouse models. (a) Models used for ex vivo tissue labeling: PFF-injected mouse (C57BL6), where PFF was injected directly into the brain or duodenum, and transgenic mouse models overexpressing human α-syn; (b) Confocal microscopy of brain tissues after 30 days of PFF injection showing high levels of α-syn aggregation in the hippocampal and cortex regions, labeled specifically by both pS129 α-syn antibody and P1 ; (c) Confocal microscopy of duodenum tissues after 75 days of PFF injection showing low levels of α-syn aggregation in the mucosa region indicated by the white arrows. Images of tissues from control PBS-injected mice are shown in Figure S5 for comparison; (d) Confocal microscopy of brain tissue (substantia nigra) of a healthy control and of a PD patient (post-mortem), with pS129 α-syn antibody staining and P1 staining observed in the substantia nigra of the PD patient; (e) Confocal microscopy showing Lewy bodies (LB) and Lewy neurites (LN) highlighted by pS129 α-syn antibody staining in the substantia nigra of a PD patient. Higher magnification images of LB and LN show specific labeling by P1 that corresponds to the antibody staining. Nuclei in blue, α-syn in green, pS129 α-syn in orange and probe P1 in red.

    Article Snippet: 15 μL of 2 mg/mL α-syn PFF (StressMarq SPR-324) were sonicated in an ultrasonic bath sonicator for 2.5 h at the following conditions: sweep, 37 Hz frequency, 60% power.

    Techniques: Staining, Injection, Ex Vivo, Labeling, Transgenic Assay, Confocal Microscopy, Control, Comparison

    Specific α-syn antibody and probe P1 labeling of entire GI tract (esophagus, stomach, duodenum, jejunum, ileum, and colon) in transgenic mice (JAX004479). (a) Aggregated α-syn is observed in the mucosa layers and stained by both pS129 α-syn antibody and P1 (annotated with white arrows). Tissue layers are indicated by black arrows: muscularis externa (ME), submucosa (SM), and mucosa (M). Nuclei are in blue, α-syn in green, pS129 α-syn in orange, and probe in red. Scale bar represents 200 μm; (b) Total expression areas of α-syn aggregates labeled by pS129 α-syn antibody and P1 were quantified, with the highest expressions observed in the esophagus and colon; (c) High degree of colocalization (average of 0.91) was observed between pS129 α-syn antibody and probe P1 channels across all the GI tract tissues, determined by the Costes method. Manders colocalization and correlation coefficients are shown in Figure S7a ; (d) Probe positive predictive values were consistent across the respective GI tract tissues. Values on graphs are given as the mean ± SEM ( n = 3 per group); (e) P1 labeling is observed in the enteric neurons in colon tissue, marked by neuronal marker TUBB3 (green).

    Journal: ACS Chemical Neuroscience

    Article Title: Fluorescence Detection of Alpha-Synuclein Aggregates in the Gut Using a Peptide Probe

    doi: 10.1021/acschemneuro.6c00069

    Figure Lengend Snippet: Specific α-syn antibody and probe P1 labeling of entire GI tract (esophagus, stomach, duodenum, jejunum, ileum, and colon) in transgenic mice (JAX004479). (a) Aggregated α-syn is observed in the mucosa layers and stained by both pS129 α-syn antibody and P1 (annotated with white arrows). Tissue layers are indicated by black arrows: muscularis externa (ME), submucosa (SM), and mucosa (M). Nuclei are in blue, α-syn in green, pS129 α-syn in orange, and probe in red. Scale bar represents 200 μm; (b) Total expression areas of α-syn aggregates labeled by pS129 α-syn antibody and P1 were quantified, with the highest expressions observed in the esophagus and colon; (c) High degree of colocalization (average of 0.91) was observed between pS129 α-syn antibody and probe P1 channels across all the GI tract tissues, determined by the Costes method. Manders colocalization and correlation coefficients are shown in Figure S7a ; (d) Probe positive predictive values were consistent across the respective GI tract tissues. Values on graphs are given as the mean ± SEM ( n = 3 per group); (e) P1 labeling is observed in the enteric neurons in colon tissue, marked by neuronal marker TUBB3 (green).

    Article Snippet: 15 μL of 2 mg/mL α-syn PFF (StressMarq SPR-324) were sonicated in an ultrasonic bath sonicator for 2.5 h at the following conditions: sweep, 37 Hz frequency, 60% power.

    Techniques: Labeling, Transgenic Assay, Staining, Expressing, Marker

    Increased accumulation of α-syn aggregates across GI tissues in older transgenic mice (JAX010799). (a) Western blot showing abundance of total α-syn in brain, esophagus, duodenum, and colon of young (5-month) and old (15-month) transgenic mice (JAX010799), with higher molecular weight α-syn species observed in the older mice (indicated by red arrows); (b) Graph showing intensity of bands corresponding to α-syn, normalized to beta-actin, quantified from blots in Figure S7 . Older mice showed increased intensities of α-syn bands; Confocal images showing increased staining of aggregated α-syn in (c) esophagus and (d) colon of older transgenic mice. Tissue layers as indicated by black arrows: muscularis externa (ME), submucosa (SM), mucosa (M). Scale bar represents 200 μm; (e) Graphs showing degree of α-syn aggregation determined by pS129 α-syn antibody labeling and P1 labeling, with generally higher degrees of α-syn aggregation observed across all GI tissues in older mice. Values on graphs are given as the mean ± SEM ( n = 3 per group). Ns: not significant; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001, determined by two-way ANOVA test.

    Journal: ACS Chemical Neuroscience

    Article Title: Fluorescence Detection of Alpha-Synuclein Aggregates in the Gut Using a Peptide Probe

    doi: 10.1021/acschemneuro.6c00069

    Figure Lengend Snippet: Increased accumulation of α-syn aggregates across GI tissues in older transgenic mice (JAX010799). (a) Western blot showing abundance of total α-syn in brain, esophagus, duodenum, and colon of young (5-month) and old (15-month) transgenic mice (JAX010799), with higher molecular weight α-syn species observed in the older mice (indicated by red arrows); (b) Graph showing intensity of bands corresponding to α-syn, normalized to beta-actin, quantified from blots in Figure S7 . Older mice showed increased intensities of α-syn bands; Confocal images showing increased staining of aggregated α-syn in (c) esophagus and (d) colon of older transgenic mice. Tissue layers as indicated by black arrows: muscularis externa (ME), submucosa (SM), mucosa (M). Scale bar represents 200 μm; (e) Graphs showing degree of α-syn aggregation determined by pS129 α-syn antibody labeling and P1 labeling, with generally higher degrees of α-syn aggregation observed across all GI tissues in older mice. Values on graphs are given as the mean ± SEM ( n = 3 per group). Ns: not significant; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001, determined by two-way ANOVA test.

    Article Snippet: 15 μL of 2 mg/mL α-syn PFF (StressMarq SPR-324) were sonicated in an ultrasonic bath sonicator for 2.5 h at the following conditions: sweep, 37 Hz frequency, 60% power.

    Techniques: Transgenic Assay, Western Blot, Molecular Weight, Staining, Antibody Labeling, Labeling

    Longitudinal view of unrolled colon tissue of transgenic mouse showing differing levels of α-syn aggregation across tissue layers (mucosa, submucosa and muscularis externa). (a) Confocal microscopy of selected section of colon tissue from transgenic mouse, with the different tissue layers marked by white dashed lines. α-Syn aggregates on the mucosa surface are specifically labeled by pS129 α-syn antibody (orange) and P1 (red). Full view of section is shown in Figure S8 ; (b) Graph showing degree of α-syn aggregation (pS129 α-syn antibody or P1 positives, divided by α-syn positives) in the mucosa, submucosa, and muscularis externa regions. Mucosa shows lower but detectable levels of P1 staining compared to the other tissue layers; (c) Confocal microscopy of colon tissue from a transgenic mouse, flushed with P1 (15 μg/mL), followed by fixation and immunofluorescence staining with pS129 α-syn antibody (orange) and aggregated α-syn antibody, clone 5G4 (green). P1 labels α-syn aggregates in the surface mucosal layer.

    Journal: ACS Chemical Neuroscience

    Article Title: Fluorescence Detection of Alpha-Synuclein Aggregates in the Gut Using a Peptide Probe

    doi: 10.1021/acschemneuro.6c00069

    Figure Lengend Snippet: Longitudinal view of unrolled colon tissue of transgenic mouse showing differing levels of α-syn aggregation across tissue layers (mucosa, submucosa and muscularis externa). (a) Confocal microscopy of selected section of colon tissue from transgenic mouse, with the different tissue layers marked by white dashed lines. α-Syn aggregates on the mucosa surface are specifically labeled by pS129 α-syn antibody (orange) and P1 (red). Full view of section is shown in Figure S8 ; (b) Graph showing degree of α-syn aggregation (pS129 α-syn antibody or P1 positives, divided by α-syn positives) in the mucosa, submucosa, and muscularis externa regions. Mucosa shows lower but detectable levels of P1 staining compared to the other tissue layers; (c) Confocal microscopy of colon tissue from a transgenic mouse, flushed with P1 (15 μg/mL), followed by fixation and immunofluorescence staining with pS129 α-syn antibody (orange) and aggregated α-syn antibody, clone 5G4 (green). P1 labels α-syn aggregates in the surface mucosal layer.

    Article Snippet: 15 μL of 2 mg/mL α-syn PFF (StressMarq SPR-324) were sonicated in an ultrasonic bath sonicator for 2.5 h at the following conditions: sweep, 37 Hz frequency, 60% power.

    Techniques: Transgenic Assay, Confocal Microscopy, Labeling, Staining, Immunofluorescence